Allspring Global Investments’s Rallybio RLYB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-58
Closed -$2.63K 2878
2023
Q2
$2.63K Buy
+58
New +$2.84K ﹤0.01% 2618
2023
Q1
Sell
-126
Closed -$6.61K 2915
2022
Q4
$6.61K Sell
126
-3
-2% -$177 ﹤0.01% 2762
2022
Q3
$14K Buy
+129
New +$11.5K ﹤0.01% 2680
2022
Q2
Sell
-556
Closed -$31K 2888
2022
Q1
$31K Buy
556
+192
+53% +$15.9K ﹤0.01% 2902
2021
Q4
$27K Buy
+364
New +$42.4K ﹤0.01% 2891

Other funds holding RLYB

Allspring Global Investments's RLYB Position: Q3 2023 in Review

Allspring Global Investments sold out of Rallybio (RLYB) in Q3 2023, closing a stake of 58 shares — an estimated $2.63K sold.

Allspring Global Investments first reported a position in RLYB in Q4 2021 and held it in 5 quarters. The position peaked at $31K in Q1 2022. 58 funds tracked by Wall St. Rank hold RLYB as of Q3 2023.

  • Allspring Global Investments reported no remaining Rallybio position as of Q3 2023 after selling out during the quarter.
  • Allspring Global Investments sold 58 Rallybio shares in Q3 2023, an estimated $2.63K.
  • Allspring Global Investments first reported a position in Rallybio in Q4 2021 and held it in 5 quarters.
  • Allspring Global Investments's Rallybio position peaked at $31K in Q1 2022.
  • 58 funds tracked by Wall St. Rank held Rallybio as of Q3 2023.

Based on Allspring Global Investments's 13F filing for Q3 2023, filed 27 Oct 2023.